CORONA, ANGELA
 Distribuzione geografica
Continente #
EU - Europa 267.841
NA - Nord America 9.162
AS - Asia 3.555
SA - Sud America 660
AF - Africa 127
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 281.368
Nazione #
IT - Italia 265.433
US - Stati Uniti d'America 9.029
CN - Cina 1.477
SG - Singapore 1.269
SE - Svezia 642
BR - Brasile 532
UA - Ucraina 496
DE - Germania 345
VN - Vietnam 242
GB - Regno Unito 199
FI - Finlandia 193
BY - Bielorussia 120
FR - Francia 101
IN - India 91
KR - Corea 86
CA - Canada 81
HK - Hong Kong 80
AR - Argentina 60
NL - Olanda 60
AT - Austria 55
MA - Marocco 52
JP - Giappone 45
MX - Messico 39
PL - Polonia 38
PK - Pakistan 34
BD - Bangladesh 31
IR - Iran 31
ZA - Sudafrica 31
BE - Belgio 30
ES - Italia 27
TR - Turchia 26
ID - Indonesia 20
EC - Ecuador 19
IQ - Iraq 19
RU - Federazione Russa 18
IE - Irlanda 17
CO - Colombia 15
UZ - Uzbekistan 14
CZ - Repubblica Ceca 12
EG - Egitto 12
IL - Israele 12
TW - Taiwan 12
AU - Australia 11
VE - Venezuela 11
AZ - Azerbaigian 10
DK - Danimarca 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
CH - Svizzera 7
EU - Europa 7
KE - Kenya 7
LT - Lituania 7
SA - Arabia Saudita 7
TN - Tunisia 7
JO - Giordania 6
LV - Lettonia 6
NO - Norvegia 6
BO - Bolivia 5
DZ - Algeria 5
PY - Paraguay 5
CL - Cile 4
GE - Georgia 4
KG - Kirghizistan 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
ET - Etiopia 3
GR - Grecia 3
NZ - Nuova Zelanda 3
A1 - Anonimo 2
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
DO - Repubblica Dominicana 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PH - Filippine 2
TH - Thailandia 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
GH - Ghana 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
MU - Mauritius 1
Totale 281.361
Città #
Cagliari 258.295
Uta 6.195
Ashburn 906
Fairfield 842
Woodbridge 702
Singapore 576
Chandler 560
Dallas 542
Nyköping 430
Houston 406
Boardman 397
Seattle 361
Wilmington 345
Beijing 336
Ann Arbor 313
Cambridge 279
Jacksonville 224
New York 214
Los Angeles 193
Dearborn 190
Shanghai 152
Santa Clara 146
Hefei 116
Boston 109
Nanjing 109
Dong Ket 98
Helsinki 96
The Dalles 89
Seoul 81
Hong Kong 71
Chicago 65
Rome 65
Buffalo 62
San Diego 62
Redwood City 61
Munich 60
Ho Chi Minh City 56
Milan 52
Herndon 47
Casablanca 43
São Paulo 42
Hangzhou 37
Redondo Beach 37
Vienna 36
Tokyo 33
Changsha 32
Mountain View 32
Sassari 32
London 31
Guangzhou 30
Tianjin 30
Toronto 30
Nanchang 29
Phoenix 29
Amsterdam 27
Verona 27
Washington 27
Atlanta 26
Redmond 26
Shenyang 26
Warsaw 26
Nuremberg 23
Rio de Janeiro 23
Salt Lake City 23
Hanoi 22
Hebei 22
Frankfurt am Main 21
Jiaxing 21
Brooklyn 20
Brussels 20
Johannesburg 19
Chennai 18
Lappeenranta 18
Norwalk 18
Montreal 17
Columbus 16
Dublin 16
Ottawa 16
San Francisco 16
Curitiba 15
Gujranwala 15
Denver 14
Jinan 14
Mexico City 14
Pittsburgh 14
Tashkent 14
Wuhan 14
Manchester 13
Mumbai 13
Zhengzhou 13
Council Bluffs 12
Elk Grove Village 12
Orange 12
Pune 12
Turku 12
Düsseldorf 11
Jakarta 11
Kunming 11
Tampa 11
Baku 10
Totale 275.207
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.687
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.025
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.628
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.481
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.397
Biological activities of aerial parts extracts of Euphorbia characias 4.392
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.290
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.143
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.707
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.482
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.407
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.401
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.394
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.374
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.332
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.282
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.277
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.266
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.260
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.229
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.155
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.061
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.043
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.040
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.019
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.002
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 2.984
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 2.963
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 2.938
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.931
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.887
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.878
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.869
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.863
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.847
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.835
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.833
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.816
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.789
Insights into Ebola VP35 oligomerization from molecular simulations 2.767
null 2.746
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.745
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.737
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.694
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.680
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.607
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.595
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.579
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.524
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.415
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.402
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.364
An efficient route to novel uracil-based drug-like molecules 2.339
null 2.329
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.306
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.278
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.226
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.217
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.208
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.122
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.097
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.096
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.063
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.057
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.043
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.038
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.032
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.929
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.846
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.842
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.831
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.825
null 1.820
Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H 1.775
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.755
The traditional Chinese medicine plant Schisandra Chinensis as source of new HIV-1 reverse transcriptase inhibitor scaffolds effective also on non-nucleoside resistant reverse transcriptases 1.752
New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function 1.680
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.669
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 1.649
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.579
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.578
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen 1.540
From classic to innovative approaches in HIV-1 infection treatment 1.521
Hypericum hircinum L. components as new single molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. 1.511
Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives 1.509
2-methoxynaphthalen thiazole derivate : a new HIV-1 RT Ribonuclease H/DNA polymerase dual inhibitor active on viral replication 1.471
Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development? 1.410
Peptides Mimicking the β7/β8 loop of HIV-1 Reverse Transcriptase p51 as “Hotspot-Targeted” Dimerization Inhibitors 1.400
Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2 1.399
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules 1.382
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production 1.367
5-arylaminouracil derivatives as potential dual-action agents 1.323
Natural and Nature-Derived Products Targeting Human Coronaviruses 1.259
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities 1.251
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation 1.221
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort 1.168
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.136
A combined cell based and site directed mutagenesis approach defines highly conserved residues involved in the selective inhibition of the HIV-1 ribonuclease H function by diketoacid derivatives 1.104
In Vitro Anti-HIV-1 Reverse Transcriptase and Integrase Properties of Punica granatum L. Leaves, Bark, and Peel Extracts and Their Main Compounds 1.078
The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry 990
Totale 258.083
Categoria #
all - tutte 335.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 335.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125.769 0 0 0 0 0 6.212 4.116 3.783 1.710 3.947 4.211 1.790
2021/202215.606 1.541 1.302 877 903 1.139 1.247 897 907 1.513 1.470 1.799 2.011
2022/202326.453 2.280 3.722 3.079 2.423 1.570 2.878 1.282 1.827 1.399 1.519 2.128 2.346
2023/202424.258 1.620 862 1.324 1.822 2.331 4.147 3.191 2.097 1.158 1.331 2.071 2.304
2024/202550.727 13.089 15.338 7.484 4.880 2.332 2.847 2.652 236 492 377 448 552
2025/20265.051 877 412 1.483 1.103 1.099 77 0 0 0 0 0 0
Totale 282.028